Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Terazosin and finasteride together cause no major issues.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Some Thai plants, especially Carthamus tinctorius, could help prevent hair loss and promote hair growth without adverse effects.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Women with PCOS have a higher risk of heart disease.

New methods improve stem cell delivery for heart disease, but challenges remain.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

5α-Reductase inhibitors, like finasteride, can cause serious, persistent side effects not always listed in official drug information.

Lower testosterone levels may increase heart failure risk in older men.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

A nano-formula of quercetin effectively improves heart health in metabolic syndrome.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

Baby teeth stem cells can potentially grow organs and treat diseases.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Following the DASH diet reduces mortality risk in hypertensive adults.

Women with PCOS have a higher risk of heart disease.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.